Financial Architects (New Jersey)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Financial Architects (New Jersey)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$29K	–	616
2020 Q2	$29K	Hold	500	–	–	0.01%	493
2020 Q1	$23K	Hold	500	–	–	0.01%	486
2019 Q4	$28K	Hold	500	–	–	0.01%	517
2019 Q3	$24K	Hold	500	–	–	0.01%	562
2019 Q2	$27K	Hold	500	–	–	0.01%	646
2019 Q1	$28K	Hold	500	–	–	﹤0.01%	784
2018 Q4	$24K	Hold	500	–	–	﹤0.01%	762
2018 Q3	$30K	Hold	500	–	–	﹤0.01%	807
2018 Q2	$27K	Hold	500	–	–	﹤0.01%	732
2018 Q1	$25K	Hold	500	–	–	﹤0.01%	821
2017 Q4	$24K	Hold	500	–	–	﹤0.01%	923
2017 Q3	$25K	Hold	500	–	–	﹤0.01%	909
2017 Q2	$23K	Hold	500	–	–	﹤0.01%	913
2017 Q1	$21K	Sell	500 -250	-33%	-$10.5K	﹤0.01%	928
2016 Q4	$29K	Hold	750	–	–	0.01%	736
2016 Q3	$31K	Hold	750	–	–	0.01%	717
2016 Q2	$28K	Hold	750	–	–	0.01%	697
2016 Q1	$29K	Buy	+750	New	+$29.1K	0.01%	507
2015 Q3	–	Sell	-750	Closed	-$44K	–	699
2015 Q2	$44K	Buy	+750	New	+$42.9K	0.02%	464
2015 Q1	–	Sell	-750	Closed	-$38K	–	1001
2014 Q4	$38K	Hold	750	–	–	0.02%	390
2014 Q3	$35K	Hold	750	–	–	0.02%	367
2014 Q2	$33K	Buy	+750	New	+$30.4K	0.02%	391
2013 Q4	–	Sell	-750	Closed	-$26K	–	436
2013 Q3	$26K	Hold	750	–	–	0.02%	336
2013 Q2	$22K	Buy	+750	New	+$21.3K	0.02%	346

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Financial Architects (New Jersey)'s PBE Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2020, closing a stake of 500 shares — an estimated $29K sold.

Financial Architects (New Jersey) first reported a position in PBE in Q2 2013 and held it in 24 quarters. The position peaked at $44K in Q2 2015. 73 funds tracked by Wall St. Rank hold PBE as of Q3 2020.

Financial Architects (New Jersey) reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 500 Invesco Biotechnology & Genome ETF shares in Q3 2020, an estimated $29K.
Financial Architects (New Jersey) first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 24 quarters.
Financial Architects (New Jersey)'s Invesco Biotechnology & Genome ETF position peaked at $44K in Q2 2015.
73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.